Barry E. Greene

Companies

• Dyne Therapeutics, Inc.Board member Jun 23, 2026 to now¹
• Sage Therapeutics, Inc.Chief executive officer Jan 6, 2021 to now²
• Sage Therapeutics, Inc.President Jan 6, 2021 to now²
• Sage Therapeutics, Inc.Board member Oct 5, 2020 to now³
• Karyopharm Therapeutics Inc.Board member Nov 5, 2013 to now⁴
• Acorda TherapeuticsBoard member Jan 10, 2007 to Jun 4, 2021⁵
• BCLS Acquisition Corp.Board member Oct 22, 2020 to Oct 22, 2020⁶
• Alnylam PharmaceuticalsPresident Dec 14, 2007 to Sep 11, 2020⁷
• Alnylam PharmaceuticalsChief operating officer Nov 1, 2006 to Mar 28, 2016⁸
• Regulus Therapeutics Inc.Board member Oct 4, 2012 to Nov 7, 2012⁹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKaryopharm Therapeutics Inc. KPTI16,415 shares¹⁰$5.8K at $0.35May 21, 2026
• STSage Therapeutics, Inc.0 shares¹¹Jul 31, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• May 21, 2026Granted 15,508 shares of Karyopharm Therapeutics Inc.¹⁰
• Jul 31, 2025Returned to company 53,229 shares of Sage Therapeutics, Inc.¹¹
• Jul 31, 2025U 46,940 shares of Sage Therapeutics, Inc.¹¹
• Apr 10, 2025Shares withheld for tax 4,862 shares at $6.91 of Sage Therapeutics, Inc.¹²
• Apr 10, 2025Granted 19,964 shares of Sage Therapeutics, Inc.¹²
• Aug 5, 2024Shares withheld for tax 12,273 shares at $8.96 of Sage Therapeutics, Inc.¹³
• Aug 5, 2024Granted 50,400 shares of Sage Therapeutics, Inc.¹³
• Nov 10, 2022Bought 14,500 shares at $34.48 of Sage Therapeutics, Inc.¹⁴
• Aug 11, 2022Exercised options 7,576 shares at $1.49 of Karyopharm Therapeutics Inc.¹⁵